Deka Bank Deutsche Girozentrale Albireo Pharma, Inc. Transaction History

Deka Bank Deutsche Girozentrale

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$16.32 - $26.37 $163,200 - $263,700	10,000 Added 28.57%	45,000 $823,000
Q2 2022 Aug 03, 2022	BUY	$18.54 - $37.29 $648,900 - $1.31 Million	35,000 New	35,000 $654,000
Q3 2021 Oct 22, 2021	SELL	$27.36 - $35.98 $927,504 - $1.22 Million	-33,900 Closed	0 $0
Q4 2020 Mar 12, 2021	SELL	$31.56 - $42.16 $53,652 - $71,672	-1,700 Reduced 4.78%	33,900 $1.25 Million
Q3 2020 Oct 29, 2020	BUY	$23.19 - $41.61 $825,564 - $1.48 Million	35,600 New	35,600 $1.13 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.